Abstract
Since the development of sulfasalazine about a half century ago, the prognosis for patients with ulcerative colitis has improved significantly. Very recently, the active moiety of oral sulfasalazine, 5-aminosalicylic acid, has been made available as a topical (enema) preparation. In this article, Dr. Bruckstein reviews the advantages of the enemas in the treatment of ulcerative colitis and briefly examines the potential benefits of the new oral salicylate preparations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
